SearcharxivSearch

arXiv subjects

Allyson Mateja

Publications and source records attributed to Allyson Mateja.

2 recordsLinked to original sources

Comparing Two Survival Functions at a Fixed Timepoint

For comparing two survival curves at a fixed timepoint with right censoring, a standard method uses asymptotic methods on two Kaplan-Meier estimators with Greenwood variance estimators and transformations using the delta method. Confidence intervals on associated estimands can either breakdown or undercover due to Kaplan-Meier estimates of zero or one, small sample sizes, or heavy censoring. Although others have proposed adjustments to the Greenwood variance for a single sample, these adjustments have not been incorporated into the two-sample application of the delta method and we do that here as well as provide modifications when Kaplan-Meier estimates are zero or one. An alternative non-asymptotic existing method called melding on the beta product confidence procedure (BPCP) appears to have at least nominal coverage regardless of the sample size. Without censoring the problem reduces to comparing two independent binomials and melding on the BPCP gives p-values equivalent to Fisher's exact test p-values and further gives compatible confidence intervals for treatment comparison estimands; however, the melding can be very conservative. In this paper, we expand the melding on the BPCP intervals to include mid-p versions, which are designed to achieve coverage closer to nominal without guaranteeing coverage for all cases. We study these existing methods and our minor modifications of them primarily by numerical methods or simulation. Results suggest only the melding on the BPCP can guarantee coverage in all studied scenarios, and the mid-p version most often has closest to nominal coverage. We provide R functions in the bpcp R package.

stat.ME

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams

We introduce a computationally efficient and general approach for utilizing multiple, possibly interval-censored, data streams to study complex biomedical endpoints using multistate semi-Markov models. Our motivating application is the REGEN-2069 trial, which investigated the protective efficacy (PE) of the monoclonal antibody combination REGEN-COV against SARS-CoV-2 when administered prophylactically to individuals in households at high risk of secondary transmission. Using data on symptom onset, episodic RT-qPCR sampling, and serological testing, we estimate the PE of REGEN-COV for asymptomatic infection, its effect on seroconversion following infection, and the duration of viral shedding. We find that REGEN-COV reduced the risk of asymptomatic infection and the duration of viral shedding, and led to lower rates of seroconversion among asymptomatically infected participants. Our algorithm for fitting semi-Markov models to interval-censored data employs a Monte Carlo expectation maximization (MCEM) algorithm combined with importance sampling to efficiently address the intractability of the marginal likelihood when data are intermittently observed. Our algorithm provide substantial computational improvements over existing methods and allows us to fit semi-parametric models despite complex coarsening of the data.

stat.ME